Drug Type Protein drugs |
Synonyms OCT 102, OCT102 |
Target |
Mechanism CD8 inhibitors(Cluster of differentiation 8 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization Octagon Therapeutics, Inc.Startup |
Active Organization Octagon Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatomyositis | Discovery | US | Octagon Therapeutics, Inc.Startup | 11 Jun 2024 |